OBJECTIVE: To assess the impact of an appointment-based medication synchronization (ABMS) program on medication adherence and persistence with chronic medications. DESIGN Quasiexperimental study in which study patients were matched with control patients. SETTING: Rural pharmacies in the Midwestern United States between June 30, 2011, and October 31, 2012. PATIENTS: Individuals receiving at least two refills for one of six categories of medications to treat chronic diseases (i.e., angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta blockers, dihydropyridine calcium channel blockers, thiazide diuretics, metformin, statins). INTERVENTION: Patients in the ABMS program were compared with control patients receiving usual care. MAIN OUTCOME MEASURES: 1-year adherence rates using proportion of days covered (PDC) and 1-year nonpersistence rates. RESULTS: Depending on the drug class, patients enrolled in the medication synchronization program (n = 47-81) had adherences rates of 66.1% to 75.5% during 1 year versus 37.0% to 40.8% among control patients. Program patients had 3.4 to 6.1 times greater odds of adherence compared with control patients. Control patients were 52% to 73% more likely to stop taking their chronic medications over 1 year. CONCLUSION: An ABMS program in community pharmacies was associated with improved patient adherence and reduced likelihood of nonpersistence.
OBJECTIVE: To assess the impact of an appointment-based medication synchronization (ABMS) program on medication adherence and persistence with chronic medications. DESIGN Quasiexperimental study in which study patients were matched with control patients. SETTING: Rural pharmacies in the Midwestern United States between June 30, 2011, and October 31, 2012. PATIENTS: Individuals receiving at least two refills for one of six categories of medications to treat chronic diseases (i.e., angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta blockers, dihydropyridine calcium channel blockers, thiazide diuretics, metformin, statins). INTERVENTION: Patients in the ABMS program were compared with control patients receiving usual care. MAIN OUTCOME MEASURES: 1-year adherence rates using proportion of days covered (PDC) and 1-year nonpersistence rates. RESULTS: Depending on the drug class, patients enrolled in the medication synchronization program (n = 47-81) had adherences rates of 66.1% to 75.5% during 1 year versus 37.0% to 40.8% among control patients. Program patients had 3.4 to 6.1 times greater odds of adherence compared with control patients. Control patients were 52% to 73% more likely to stop taking their chronic medications over 1 year. CONCLUSION: An ABMS program in community pharmacies was associated with improved patient adherence and reduced likelihood of nonpersistence.
Authors: Joan M Neuner; Nicole M Fergestrom; Purushottam W Laud; Ann B Nattinger; Kirsten M M Beyer; Kathryn E Flynn; Liliana E Pezzin Journal: Cancer Date: 2019-08-02 Impact factor: 6.860
Authors: Natalie S Hohmann; Tessa J Hastings; Ruth N Jeminiwa; Jingjing Qian; Richard A Hansen; Surachat Ngorsuraches; Kimberly B Garza Journal: Res Social Adm Pharm Date: 2021-02-05